191 related articles for article (PubMed ID: 19072094)
1. Synthesis and biological evaluation of a chitobiose-based peptide N-glycanase inhibitor library.
Witte MD; Horst D; Wiertz EJ; van der Marel GA; Overkleeft HS
J Org Chem; 2009 Jan; 74(2):605-16. PubMed ID: 19072094
[TBL] [Abstract][Full Text] [Related]
2. Fluorescently labeled inhibitor for profiling cytoplasmic peptide:N-glycanase.
Hagihara S; Miyazaki A; Matsuo I; Tatami A; Suzuki T; Ito Y
Glycobiology; 2007 Oct; 17(10):1070-6. PubMed ID: 17640972
[TBL] [Abstract][Full Text] [Related]
3. Systematic synthesis and inhibitory activity of haloacetamidyl oligosaccharide derivatives toward cytoplasmic peptide:N-glycanase.
Miyazaki A; Matsuo I; Hagihara S; Kakegawa A; Suzuki T; Ito Y
Glycoconj J; 2009 Feb; 26(2):133-40. PubMed ID: 18695987
[TBL] [Abstract][Full Text] [Related]
4. Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover.
Misaghi S; Pacold ME; Blom D; Ploegh HL; Korbel GA
Chem Biol; 2004 Dec; 11(12):1677-87. PubMed ID: 15610852
[TBL] [Abstract][Full Text] [Related]
5. Bodipy-VAD-Fmk, a useful tool to study yeast peptide N-glycanase activity.
Witte MD; Descals CV; de Lavoir SV; Florea BI; van der Marel GA; Overkleeft HS
Org Biomol Chem; 2007 Nov; 5(22):3690-7. PubMed ID: 17971999
[TBL] [Abstract][Full Text] [Related]
6. IRAK-4 inhibitors. Part 1: a series of amides.
Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
[TBL] [Abstract][Full Text] [Related]
7. A cytoplasmic peptide: N-glycanase.
Tanabe K; Lennarz WJ; Suzuki T
Methods Enzymol; 2006; 415():46-55. PubMed ID: 17116467
[TBL] [Abstract][Full Text] [Related]
8. Peptide Specificity Analysis of Peptide: N-glycanases Using Synthetic Chitobiose-pentapeptides.
Kuribara T; Ishihara T; Kudo T; Hirano M; Totani K
Protein Pept Lett; 2017; 24(8):723-728. PubMed ID: 28820060
[TBL] [Abstract][Full Text] [Related]
9. Misfolding of glycoproteins is a prerequisite for peptide: N-glycanase mediated deglycosylation.
Joshi S; Katiyar S; Lennarz WJ
FEBS Lett; 2005 Jan; 579(3):823-6. PubMed ID: 15670854
[TBL] [Abstract][Full Text] [Related]
10. z-VAD-fmk inhibits peptide:N-glycanase and may result in ER stress.
Misaghi S; Korbel GA; Kessler B; Spooner E; Ploegh HL
Cell Death Differ; 2006 Jan; 13(1):163-5. PubMed ID: 16003388
[No Abstract] [Full Text] [Related]
11. Structural and mutational studies on the importance of oligosaccharide binding for the activity of yeast PNGase.
Zhao G; Li G; Zhou X; Matsuo I; Ito Y; Suzuki T; Lennarz WJ; Schindelin H
Glycobiology; 2009 Feb; 19(2):118-25. PubMed ID: 18854368
[TBL] [Abstract][Full Text] [Related]
12. Site-specific labeling of cytoplasmic peptide:N-glycanase by N,N'-diacetylchitobiose-related compounds.
Suzuki T; Hara I; Nakano M; Zhao G; Lennarz WJ; Schindelin H; Taniguchi N; Totani K; Matsuo I; Ito Y
J Biol Chem; 2006 Aug; 281(31):22152-22160. PubMed ID: 16740630
[TBL] [Abstract][Full Text] [Related]
13. A simple, sensitive in vitro assay for cytoplasmic deglycosylation by peptide: N-glycanase.
Suzuki T
Methods; 2005 Apr; 35(4):360-5. PubMed ID: 15804608
[TBL] [Abstract][Full Text] [Related]
14. Molecular identification and characterization of peptide: N-glycanase from Schizosaccharomyces pombe.
Xin F; Wang S; Song L; Liang Q; Qi Q
Biochem Biophys Res Commun; 2008 Apr; 368(4):907-12. PubMed ID: 18279662
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Bi Y; Might M; Vankayalapati H; Kuberan B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2962-2966. PubMed ID: 28512024
[TBL] [Abstract][Full Text] [Related]
16. Irreversible inhibitors and activity-based probes as research tools in chemical glycobiology.
Witte MD; van der Marel GA; Aerts JM; Overkleeft HS
Org Biomol Chem; 2011 Sep; 9(17):5908-26. PubMed ID: 21769371
[TBL] [Abstract][Full Text] [Related]
17. Crystallization and preliminary crystallographic analysis of peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase PNGase F.
Kuhn P; Tarentino AL; Plummer TH; Van Roey P
J Mol Biol; 1994 Aug; 241(4):622-3. PubMed ID: 8057383
[TBL] [Abstract][Full Text] [Related]
18. Identification of peptide:N-glycanase activity in mammalian-derived cultured cells.
Suzuki T; Seko A; Kitajima K; Inoue Y; Inoue S
Biochem Biophys Res Commun; 1993 Aug; 194(3):1124-30. PubMed ID: 8352768
[TBL] [Abstract][Full Text] [Related]
19. Dual enzymatic properties of the cytoplasmic peptide: N-glycanase in C. elegans.
Suzuki T; Tanabe K; Hara I; Taniguchi N; Colavita A
Biochem Biophys Res Commun; 2007 Jul; 358(3):837-41. PubMed ID: 17509531
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial approach toward synthesis of small molecule libraries as bacterial transglycosylase inhibitors.
Shih HW; Chen KT; Chen SK; Huang CY; Cheng TJ; Ma C; Wong CH; Cheng WC
Org Biomol Chem; 2010 Jun; 8(11):2586-93. PubMed ID: 20485795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
